Literature DB >> 24729990

The trientine crisis in Canada: a call to advocacy.

Natasha Chandok, Eve A Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24729990      PMCID： PMC4071922          DOI： 10.1155/2014/672809

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN： 2291-2789


× No keyword cloud information.
  6 in total

1.  Incentives for drug development--the curious case of colchicine.

Authors:  Aaron S Kesselheim; Daniel H Solomon
Journal:  N Engl J Med       Date:  2010-04-14       Impact factor: 91.245

2.  Diagnosis and treatment of Wilson disease: an update.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2008-06       Impact factor: 17.425

3.  D-penicillamine versus zinc sulfate as first-line therapy for Wilson's disease.

Authors:  A Członkowska; T Litwin; M Karliński; K Dziezyc; G Chabik; M Czerska
Journal:  Eur J Neurol       Date:  2014-01-21       Impact factor: 6.089

4.  Efficacy and safety of oral chelators in treatment of patients with Wilson disease.

Authors:  Karl Heinz Weiss; Florentine Thurik; Daniel Nils Gotthardt; Mark Schäfer; Ulrike Teufel; Franziska Wiegand; Uta Merle; Daniela Ferenci-Foerster; Andreas Maieron; Rudolf Stauber; Heinz Zoller; Hartmut H Schmidt; Ulrike Reuner; Harald Hefter; Jean Marc Trocello; Roderick H J Houwen; Peter Ferenci; Wolfgang Stremmel
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-28       Impact factor: 11.382

5.  Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients.

Authors:  J M Walshe
Journal:  Q J Med       Date:  1989-03

6.  The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease.

Authors:  I H Scheinberg; M E Jaffe; I Sternlieb
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245
  6 in total
  2 in total

Review 1.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

Review 2.  Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.

Authors:  Eve A Roberts; Matthew Herder; Aidan Hollis
Journal:  CMAJ       Date:  2015-02-23       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.